Novartis Pharma The Business Unit Model case solution

Case Solution

In June 2000, Novartis restructured its pharmaceutical business division to develop international business entities in oncology, transplantation, ophthalmology, and mature goods. The other enduring primary care items were overlooked and supervised under international operations (e.g. R&D and marketing). The rejuvenated company initiated a matrix construct and restructured duties and job descriptions for heads of different business divisions, CEOs of new business sections, and country managers functional in more than 100 countries.